Univest
Univest
  • Markets

Medico Remedies Ltd. Hits Lower Circuit on BSE, 25 September 2026

  • September 25, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Medico Remedies Ltd. Hits Lower Circuit on BSE, 25 September 2026

On 25 September 2026, Medico Remedies Ltd. (MEDICO) hit the lower circuit on BSE at Rs 26.14, a 19.99% negative move from the previous close of Rs 32.67. The company’s market cap stood at Rs 271.11 crore. The lower circuit price for the session was Rs 26.14.

The move was driven by selling pressure against the exchange-defined price band. At the time of writing the stock was locked at its lower circuit level, which makes the session worth noting for short-term market participants.

Table of Contents

Toggle
  • Key Takeaways
  • Key Market Data
  • Price Action and Trading Activity
  • Why Medico Remedies Ltd. Hit Lower Circuit
  • What the Lower Circuit Means
  • Medico Remedies Ltd. Fundamentals and Valuation
  • Peer and Sector Context
  • Technical Snapshot
  • What Readers Should Know
  • Frequently Asked Questions
    • Why did Medico Remedies Ltd. hit lower circuit on 25 September 2026?
    • What was MEDICO share price on 25 September 2026?
    • What was the lower circuit price for MEDICO?
    • What is Medico Remedies Ltd.’s market cap and PE ratio?
    • Which exchange and data source were used?
    • Does hitting a lower circuit mean Medico Remedies Ltd. is a buy or a sell?
    • Can you buy or sell Medico Remedies Ltd. shares when the stock is at the lower circuit?
    • What happens the next trading session after a lower circuit?
    • What is the lower circuit limit set at for Indian stocks?
  • Footer Disclosure

Key Takeaways

  • Medico Remedies Ltd. (MEDICO) hit the lower circuit on BSE at Rs 26.14 on 25 September 2026.
  • The session move was -19.99% against a previous close of Rs 32.67.
  • Market capitalisation stood at Rs 271.11 crore with a PE ratio of 19.62.
  • No official company announcement or verified catalyst was confirmed at the time of writing.
  • A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric Value
Stock Medico Remedies Ltd.
Current Price / LTP Rs 26.14
Day Move -19.99%
Previous Close Rs 32.67
Day Open Rs 33.13
Day High Rs 33.13
Day Low Rs 26.14
Lower Circuit Price Rs 26.14
Lower Circuit Limit Rs 26.14
Market Cap Rs 271.11 crore
Selected Exchange BSE
PE Ratio 19.62

All figures above are as of 25 September 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Medico Remedies Ltd. opened at Rs 33.13 on BSE, compared with a previous close of Rs 32.67. During the session, the stock traded between Rs 26.14 and Rs 33.13 before touching the lower circuit price of Rs 26.14.

The absolute day change was Rs 6.53, while the percentage move was -19.99%. The event figures are kept to a single exchange so the numbers stay comparable.

The selected exchange matters because price bands, day range and previous-close values can differ across exchanges. This article uses BSE consistently for the event table and narrative. The stated lower circuit limit for the session was Rs 26.14, which is the level the price reached.

Why Medico Remedies Ltd. Hit Lower Circuit

Medico Remedies Ltd. hit the lower circuit after selling pressure pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.

Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.

Within the session the stock reached the lower circuit level of Rs 26.14.

What the Lower Circuit Means

A lower circuit is the minimum price level a stock is allowed to reach during a trading session under the applicable exchange price band. For Medico Remedies Ltd., the captured lower circuit price was Rs 26.14 on 25 September 2026.

The circuit mechanism is meant to slow extreme price movement and keep trading orderly. It is a market-structure fact, not a return forecast. In this article, the lower circuit explains what happened in the session and where the price band was reached.

Medico Remedies Ltd. Fundamentals and Valuation

Available market data gives a fuller picture than price action alone. For Medico Remedies Ltd., PE ratio was 19.62, PB ratio was 3.48, book value was Rs 9.4, EPS was 1.66, ROE was 19.02%, ROCE was 23.28%, dividend yield was 0% and debt-to-assets ratio was 0.25, on a market cap of Rs 271.11 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.

At the reported PB ratio of 3.48, the market valued Medico Remedies Ltd. above its reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.

For investors tracking lower circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.

Peer and Sector Context

Medico Remedies Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company Market Cap PE PB ROE
Advanced Enzyme Technologies Ltd. Rs 3277.54 crore 19.76 1.97 11.43%
Hikal Ltd. Rs 2641.1 crore – 2.22 -3.97%
Dishman Carbogen Amcis Ltd. Rs 2640.23 crore 163.38 0.4 1.56%
Sakar Healthcare Ltd. Rs 2511.01 crore 69.56 7.5 6.48%
Beta Drugs Ltd. Rs 2328.12 crore 56.12 8.88 23.95%

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Several of these peers are far larger by market capitalisation than Medico Remedies Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Medico Remedies Ltd.’s PE ratio was 19.62, compared with an available peer PE average of 77.21, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Want to know more? Log in to Univest for more stock insights.

Technical Snapshot

The technical snapshot adds context: RSI was 44.88, the 50-day moving average was 38.5 and the 200-day moving average was 41.98.

What Readers Should Know

The main confirmed fact is that Medico Remedies Ltd. hit the lower circuit on BSE at Rs 26.14 on 25 September 2026, with a -19.99% day move.

The practical limitation after a lower-circuit session is execution. Sellers queue at the band with few buyers, so exiting at the quoted price may not be possible. The other limitation is that no official catalyst was confirmed at the time of writing.

Readers should treat lower circuit events as market updates, not standalone investment conclusions. The price band shows heavy near-term selling pressure, but follow-up analysis should consider business fundamentals, valuation, liquidity, risk, and confirmed company disclosures.

Frequently Asked Questions

Why did Medico Remedies Ltd. hit lower circuit on 25 September 2026?

The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was MEDICO share price on 25 September 2026?

The last traded price used in this article was Rs 26.14 on BSE. That price matched the lower circuit price captured for the event.

What was the lower circuit price for MEDICO?

The lower circuit price was Rs 26.14. The stated exchange lower circuit limit was Rs 26.14. The event numbers in this article are aligned to BSE.

What is Medico Remedies Ltd.’s market cap and PE ratio?

Medico Remedies Ltd.’s market cap was Rs 271.11 crore. PE ratio was 19.62.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 25 September 2026.

Does hitting a lower circuit mean Medico Remedies Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Medico Remedies Ltd. shares when the stock is at the lower circuit?

It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.

What happens the next trading session after a lower circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the lower circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Medico Remedies Ltd. the stated limit was Rs 26.14. For this session, Medico Remedies Ltd. moved -19.99%.

Footer Disclosure

Uniresearch Global Pvt. Ltd.
Research Analyst
SEBI Registration Number- INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply